Evaluation of Inhaled Alprostadil in Hospitalized Adult Patients.
acute respiratory distress syndrome
alprostadil
epoprostenol
inhaled nitric oxide
right ventricular failure
Journal
The Annals of pharmacotherapy
ISSN: 1542-6270
Titre abrégé: Ann Pharmacother
Pays: United States
ID NLM: 9203131
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
pubmed:
7
9
2021
medline:
15
4
2022
entrez:
6
9
2021
Statut:
ppublish
Résumé
Intermittent inhaled alprostadil (iPGE To describe the clinical characteristics of patients receiving iPGE This was a single-center, retrospective, descriptive analysis of inpatients who received at least one dose of iPGE Fifty-four patients received iPGE This is the largest study to date on the use of intermittent iPGE
Sections du résumé
BACKGROUND
Intermittent inhaled alprostadil (iPGE
OBJECTIVE
To describe the clinical characteristics of patients receiving iPGE
METHODS
This was a single-center, retrospective, descriptive analysis of inpatients who received at least one dose of iPGE
RESULTS
Fifty-four patients received iPGE
CONCLUSION AND RELEVANCE
This is the largest study to date on the use of intermittent iPGE
Identifiants
pubmed: 34486414
doi: 10.1177/10600280211042675
doi:
Substances chimiques
Nitric Oxide
31C4KY9ESH
Epoprostenol
DCR9Z582X0
Alprostadil
F5TD010360
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM